EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling events leading to cell transformation. However, it remains elusive how genetically homogeneous EwS cells can drive the heterogeneity of transcriptional programs. Here, we combine independent component analysis of single-cell RNA sequencing data from diverse cell types and model systems with time-resolved mapping of EWSR1-FLI1 binding sites and of open chromatin regions to characterize dynamic cellular processes associated with EWSR1-FLI1 activity. We thus define an exquisitely specific and direct enhancer-driven EWSR1-FLI1 program. In EwS tumors, cell proliferation and strong oxidative phosphorylation metabolism are associated with a well-defi...
Ewing's sarcoma is characterized by the presence of fusion oncoproteins involving EWSR1 and an ETS g...
Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TF...
Ewing sarcoma is the second most common bone tumor in childhood and adolescence. Currently, first-li...
EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling e...
EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling e...
EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangement, specifi...
Ewing sarcoma is an aggressive bone and soft tissue tumor that primarily arises in children and adol...
SummaryThe aberrant transcription factor EWS-FLI1 drives Ewing sarcoma, but its molecular function i...
Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangem...
Ewing sarcoma (EwS), a type of bone and soft tissue tumor, is mainly driven by the expression of the...
Ewing sarcoma (EwS) is characterized by EWSR1-ETS fusion transcription factors converting polymorphi...
AbstractEwing sarcoma breakpoint region 1 (EWSR1) fusion with Friend leukemia integration 1 transcri...
The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing ...
International audienceEwing sarcoma is the second most frequent pediat-ric bone tumor. In most of th...
Ewing sarcoma (EwS) is a highly aggressive pediatric bone cancer that is defined by a somatic fusion...
Ewing's sarcoma is characterized by the presence of fusion oncoproteins involving EWSR1 and an ETS g...
Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TF...
Ewing sarcoma is the second most common bone tumor in childhood and adolescence. Currently, first-li...
EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling e...
EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a cascade of signaling e...
EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangement, specifi...
Ewing sarcoma is an aggressive bone and soft tissue tumor that primarily arises in children and adol...
SummaryThe aberrant transcription factor EWS-FLI1 drives Ewing sarcoma, but its molecular function i...
Background: EWS-FLI1 is a chimeric ETS transcription factor that is, due to a chromosomal rearrangem...
Ewing sarcoma (EwS), a type of bone and soft tissue tumor, is mainly driven by the expression of the...
Ewing sarcoma (EwS) is characterized by EWSR1-ETS fusion transcription factors converting polymorphi...
AbstractEwing sarcoma breakpoint region 1 (EWSR1) fusion with Friend leukemia integration 1 transcri...
The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing ...
International audienceEwing sarcoma is the second most frequent pediat-ric bone tumor. In most of th...
Ewing sarcoma (EwS) is a highly aggressive pediatric bone cancer that is defined by a somatic fusion...
Ewing's sarcoma is characterized by the presence of fusion oncoproteins involving EWSR1 and an ETS g...
Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription factors (TF...
Ewing sarcoma is the second most common bone tumor in childhood and adolescence. Currently, first-li...